The Nature of Things poster
Tuesday, 13 November 2001

Are our regulatory agencies doing their best to ensure drug safety? Or are they buckling to corporate pressure to market lucrative new drugs before they are adequately tested? These are questions raised in DRUG DEALS: THE BRAVE NEW WORLD OF PRESCRIPTION DRUGS.

View all episodes of The Nature of Things